(Q44534203)

3 December 2017

title

Lung deposition and systemic availability of fluticasone Diskus and budesonide Turbuhaler in children (English)

1 reference

3 December 2017

Lone Agertoft

1

1 reference

3 December 2017

Soren Pedersen

series ordinal

2

1 reference

3 December 2017

language of work or name

English

0 references

publication date

31 July 2003

1 reference

American Journal of Respiratory and Critical Care Medicine

3 December 2017

published in

1 reference

3 December 2017

volume

168

1 reference

3 December 2017

issue

7

1 reference

3 December 2017

page(s)

779-782

1 reference

Dose-proportional pharmacokinetics of budesonide inhaled via Turbuhaler

3 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200302-200OC

The influence of orally deposited budesonide on the systemic availability of budesonide after inhalation from a Turbuhaler

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200302-200OC

Pharmacokinetics and systemic activity of fluticasone via Diskus and pMDI, and of budesonide via Turbuhaler

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200302-200OC

Systemic availability and pharmacokinetics of nebulised budesonide in preschool children

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200302-200OC

Systemic effect comparisons of six inhaled corticosteroid preparations

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200302-200OC

Lung deposition of hydrofluoroalkane-134a beclomethasone is greater than that of chlorofluorocarbon fluticasone and chlorofluorocarbon beclomethasone : a cross-over study in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200302-200OC

Efficacy and safety of inhaled corticosteroids in asthma. Report of a workshop held in Eze, France, October 1992.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200302-200OC

Lung deposition and protective effect of terbutaline delivered from pressurized metered-dose inhalers and the Turbuhaler in asthmatic individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200302-200OC

Switching from conventional to extrafine aerosol beclomethasone dipropionate therapy in children: a 6-month, open- label, randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200302-200OC

Efficacy response of inhaled beclomethasone dipropionate in asthma is proportional to dose and is improved by formulation with a new propellant.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200302-200OC

Systemic effects of inhaled fluticasone propionate and budesonide in adult patients with asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200302-200OC

A comparison of the efficacy and safety of inhaled corticosteroids in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200302-200OC

Fine particle mass from the Diskus inhaler and Turbuhaler inhaler in children with asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200302-200OC

Lung Deposition of Inhaled Drugs Increases with Age

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200302-200OC

Variability in lung deposition of inhaled drug, within and between asthmatic patients, with a pMDI and a dry powder inhaler, Turbuhaler

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200302-200OC

Lung deposition of budesonide from Turbuhaler is twice that from a pressurized metered-dose inhaler P-MDI

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200302-200OC

Lung deposition from the Turbuhaler in children with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200302-200OC

Lung deposition of budesonide from turbuhaler in asthmatic children

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200302-200OC

Pharmacokinetics of fluticasone propionate inhaled via the Diskhaler and Diskus powder devices in patients with mild-to-moderate asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200302-200OC

Pharmacokinetics of fluticasone propionate inhaled via the Diskhaler and Diskus powder devices in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200302-200OC

Improved airway targeting with the CFC-free HFA-beclomethasone metered-dose inhaler compared with CFC-beclomethasone

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200302-200OC

Improved delivery of inhaled steroids to the large and small airways

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200302-200OC

The inhalation device influences lung deposition and bronchodilating effect of terbutaline

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200302-200OC

A randomized, double-blind dose reduction study to compare the minimal effective dose of budesonide Turbuhaler and fluticasone propionate Diskhaler

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200302-200OC

10.1164/RCCM.200302-200OC

21 January 2018

Identifiers

DOI

1 reference

3 December 2017

1 reference